Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: The receptor–dimer cooperativity index-Reference-Cited by-同舟云学术

Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: The receptor–dimer cooperativity index

Published:2007-12 Issue:3 Volume:116 Page:343-354
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Casadó Vincent,Cortés Antoni,Ciruela Francisco,Mallol Josefa,Ferré Sergi,Lluis Carmen,Canela Enric I.,Franco Rafael

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference57 articles.

1. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons;Agnati;Pharmacol Rev,2003

2. How receptor mosaics decode transmitter signals. Possible relevance of cooperativity;Agnati;Trends Biochem Sci,2005

3. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding;Albizu;Mol Pharmacol,2006

4. The binding of estrogen and estrogen antagonists to the estrogen receptor;Bond;Arch Biochem Biophys,1992

5. Oligomerization of G protein-coupled transmitter receptors;Bouvier;Nat Rev Neurosci,2001

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically encoded fluorescent biosensors for GPCR research;Frontiers in Cell and Developmental Biology;2022-09-29

2. Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals;International Journal of Molecular Sciences;2022-09-04

3. Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer;Pharmacological Research;2022-08

4. Unmasking allosteric-binding sites: novel targets for GPCR drug discovery;Expert Opinion on Drug Discovery;2022-06-13

5. Heterobivalent Ligand for the Adenosine A_2A–Dopamine D₂ Receptor Heteromer;Journal of Medicinal Chemistry;2022-01-04